| Product Code: ETC7507599 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Hungary Pharmacogenetic Testing Market Overview |
3.1 Hungary Country Macro Economic Indicators |
3.2 Hungary Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Hungary Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Hungary Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Hungary Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Hungary Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Hungary Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Hungary Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Hungary Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Hungary Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Hungary Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Hungary Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision healthcare |
4.2.2 Growing awareness about the benefits of pharmacogenetic testing among healthcare professionals and patients |
4.2.3 Government initiatives to promote pharmacogenetic testing and precision medicine in Hungary |
4.3 Market Restraints |
4.3.1 High costs associated with pharmacogenetic testing may limit adoption |
4.3.2 Limited availability of skilled professionals to interpret and utilize pharmacogenetic test results effectively |
4.3.3 Regulatory challenges and lack of standardized guidelines for pharmacogenetic testing in Hungary |
5 Hungary Pharmacogenetic Testing Market Trends |
6 Hungary Pharmacogenetic Testing Market, By Types |
6.1 Hungary Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Hungary Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Hungary Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Hungary Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Hungary Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Hungary Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Hungary Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Hungary Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Hungary Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Hungary Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Hungary Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Hungary Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Hungary Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Hungary Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Hungary Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Hungary Pharmacogenetic Testing Market Export to Major Countries |
7.2 Hungary Pharmacogenetic Testing Market Imports from Major Countries |
8 Hungary Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Rate of adoption of pharmacogenetic testing by healthcare providers in Hungary |
8.2 Number of clinical trials incorporating pharmacogenetic testing in the country |
8.3 Percentage of healthcare facilities offering pharmacogenetic testing services in Hungary |
9 Hungary Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Hungary Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Hungary Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Hungary Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Hungary Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Hungary Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Hungary Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Hungary Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Hungary Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Hungary Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Hungary Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here